A dose‐ranging study of ticagrelor in children aged 3‐17 years with sickle cell disease: A 2‐part phase 2 study

por Hsu, Lewis L., Sarnaik, Sharada, Williams, Suzan, Amilon, Carl, Wissmar, Jenny, Berggren, Anders
Publicado 2018

Ticagrelor does not impact patient‐reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study

por Kanter, Julie, Abboud, Miguel R., Kaya, Banu, Nduba, Videlis, Amilon, Carl, Gottfridsson, Christer, Rensfeldt, Martin, Leonsson‐Zachrisson, Maria
Publicado 2018

Pharmacokinetic–pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients

por Åstrand, Magnus, Amilon, Carl, Röshammar, Daniel, Himmelmann, Anders, Angiolillo, Dominick J., Storey, Robert F., Gurbel, Paul A., Bonaca, Marc P., Hamrén, Bengt
Publicado 2018

Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction

por Nelander, Karin, Lagerstrom‐Fermer, Maria, Amilon, Carl, Michaëlsson, Erik, Heijer, Maria, Kjaer, Magnus, Russell, Muir, Han, David, Lindstedt, Eva‐Lotte, Whatling, Carl, Gan, Li‐Ming, Ericsson, Hans
Publicado 2021

Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation

por Eijgenraam, Tim R., Stege, Nienke M., Oliveira Nunes Teixeira, Vivian, de Brouwer, Remco, Schouten, Elisabeth M., Grote Beverborg, Niels, Sun, Liu, Später, Daniela, Knöll, Ralph, Hansson, Kenny M., Amilon, Carl, Janzén, David, Yeh, Steve T., Mullick, Adam E., van der Meer, Peter, de Boer, Rudolf A., Silljé, Herman H. W.
Publicado 2022